172 related articles for article (PubMed ID: 8442301)
1. Can citrate therapy prevent nephrolithiasis?
Abdulhadi MH; Hall PM; Streem SB
Urology; 1993 Mar; 41(3):221-4. PubMed ID: 8442301
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
[TBL] [Abstract][Full Text] [Related]
4. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
6. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
7. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
8. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
9. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
10. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
[TBL] [Abstract][Full Text] [Related]
11. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
12. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
Harvey JA; Pak CY
J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
[TBL] [Abstract][Full Text] [Related]
13. Urinary citrate excretion in patients with renal calculi.
Menon M; Mahle CJ
J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
[TBL] [Abstract][Full Text] [Related]
14. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
[TBL] [Abstract][Full Text] [Related]
15. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
Alvarez Arroyo MV; Traba ML; Rapado A
Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
[TBL] [Abstract][Full Text] [Related]
16. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia.
Whalley NA; Meyers AM; Martins M; Margolius LP
Br J Urol; 1996 Jul; 78(1):10-4. PubMed ID: 8795392
[TBL] [Abstract][Full Text] [Related]
18. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
Hofbauer J; Höbarth K; Zechner O
Z Urol Nephrol; 1990 Nov; 83(11):597-602. PubMed ID: 2100085
[TBL] [Abstract][Full Text] [Related]
19. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
20. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G
Nephron; 1992; 61(1):73-6. PubMed ID: 1528345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
